Anumigilimab clinical trials

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

This study is testing a new medicine, Anumigilimab, for adults with sickle cell disease. Researchers want to see if it's safe. Participants will receive the medicine or a dummy medicine for over a year to check for side effects and how well it's tolerated. It's a key step in understanding this potential new treatment.